A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Clinical trial NCT05142306 · COMPLETED

Trial details

NCT number: NCT05142306
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-12-07
Primary completion: 2022-03-28
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.